Nab-paclitaxel in Combination With Pyrotinib in Postoperative Adjuvant Therapy for HER2-positive Breast Cancer
Clinical trial NCT04659499 · UNKNOWN
Trial details
- NCT number
- NCT04659499
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2022-06-01
- Enrollment
- 261
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.